ID   NPCL1_HUMAN             Reviewed;        1359 AA.
AC   Q9UHC9; A4D2J7; B7ZLE6; D3DVK9; Q17RV5; Q6R3Q4; Q9UHC8;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 2.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=Niemann-Pick C1-like protein 1;
DE   Flags: Precursor;
GN   Name=NPC1L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10783261; DOI=10.1006/geno.2000.6151;
RA   Davies J.P., Levy B., Ioannou Y.A.;
RT   "Evidence for a Niemann-Pick C (NPC) gene family: identification and
RT   characterization of NPC1L1.";
RL   Genomics 65:137-145(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=14976318; DOI=10.1126/science.1093131;
RA   Altmann S.W., Davis H.R. Jr., Zhu L.-J., Yao X., Hoos L.M.,
RA   Tetzloff G., Iyer S.P.N., Maguire M., Golovko A., Zeng M., Wang L.,
RA   Murgolo N., Graziano M.P.;
RT   "Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol
RT   absorption.";
RL   Science 303:1201-1204(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TOPOLOGY.
RX   PubMed=19325169; DOI=10.1194/jlr.M800669-JLR200;
RA   Wang J., Chu B.-B., Ge L., Li B.-L., Yan Y., Song B.L.;
RT   "Membrane topology of human NPC1L1, a key protein in enterohepatic
RT   cholesterol absorption.";
RL   J. Lipid Res. 50:1653-1662(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15671032; DOI=10.1074/jbc.M409110200;
RA   Davies J.P., Scott C., Oishi K., Liapis A., Ioannou Y.A.;
RT   "Inactivation of NPC1L1 causes multiple lipid transport defects and
RT   protects against diet-induced hypercholesterolemia.";
RL   J. Biol. Chem. 280:12710-12720(2005).
RN   [9]
RP   INDUCTION.
RX   PubMed=15604518; DOI=10.1194/jlr.M400400-JLR200;
RA   van der Veen J.N., Kruit J.K., Havinga R., Baller J.F.W., Chimini G.,
RA   Lestavel S., Staels B., Groot P.H.E., Groen A.K., Kuipers F.;
RT   "Reduced cholesterol absorption upon PPARdelta activation coincides
RT   with decreased intestinal expression of NPC1L1.";
RL   J. Lipid Res. 46:526-534(2005).
RN   [10]
RP   FUNCTION.
RX   PubMed=15928087; DOI=10.1073/pnas.0500269102;
RA   Garcia-Calvo M., Lisnock J., Bull H.G., Hawes B.E., Burnett D.A.,
RA   Braun M.P., Crona J.H., Davis H.R. Jr., Dean D.C., Detmers P.A.,
RA   Graziano M.P., Hughes M., MacIntyre D.E., Ogawa A., O'neill K.A.,
RA   Iyer S.P.N., Shevell D.E., Smith M.M., Tang Y.S., Makarewicz A.M.,
RA   Ujjainwalla F., Altmann S.W., Chapman K.T., Thornberry N.A.;
RT   "The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8132-8137(2005).
RN   [11]
RP   INTERACTION WITH RAB11A; MYO5B AND RAB11FIP2.
RX   PubMed=19542231; DOI=10.1074/jbc.M109.034355;
RA   Chu B.-B., Ge L., Xie C., Zhao Y., Miao H.-H., Wang J., Li B.-L.,
RA   Song B.-L.;
RT   "Requirement of myosin Vb.Rab11a.Rab11-FIP2 complex in cholesterol-
RT   regulated translocation of NPC1L1 to the cell surface.";
RL   J. Biol. Chem. 284:22481-22490(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH NPC2.
RX   PubMed=22095670; DOI=10.1002/hep.24772;
RA   Yamanashi Y., Takada T., Shoda J., Suzuki H.;
RT   "Novel function of Niemann-Pick C1-like 1 as a negative regulator of
RT   Niemann-Pick C2 protein.";
RL   Hepatology 55:953-964(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.83 ANGSTROMS) OF 22-284, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-54 AND ASN-138.
RX   PubMed=21525977; DOI=10.1371/journal.pone.0018722;
RA   Kwon H.J., Palnitkar M., Deisenhofer J.;
RT   "The structure of the NPC1L1 N-terminal domain in a closed
RT   conformation.";
RL   PLoS ONE 6:E18722-E18722(2011).
RN   [14]
RP   VARIANTS LEU-55 AND ASN-1233, AND POLYMORPHISM.
RX   PubMed=15679830; DOI=10.1111/j.1399-0004.2004.00388.x;
RA   Wang J., Williams C.M., Hegele R.A.;
RT   "Compound heterozygosity for two non-synonymous polymorphisms in
RT   NPC1L1 in a non-responder to ezetimibe.";
RL   Clin. Genet. 67:175-177(2005).
CC   -!- FUNCTION: Plays a major role in cholesterol homeostasis. Is
CC       critical for the uptake of cholesterol across the plasma membrane
CC       of the intestinal enterocyte. Is the direct molecular target of
CC       ezetimibe, a drug that inhibits cholesterol absorption. Lack of
CC       activity leads to multiple lipid transport defects. The protein
CC       may have a function in the transport of multiple lipids and their
CC       homeostasis, and may play a critical role in regulating lipid
CC       metabolism. Acts as a negative regulator of NPC2 and down-
CC       regulates its expression and secretion by inhibiting its
CC       maturation and accelerating its degradation.
CC       {ECO:0000269|PubMed:15928087, ECO:0000269|PubMed:22095670}.
CC   -!- SUBUNIT: Interacts with RAB11A, MYO5B and RAB11FIP2. Interaction
CC       with RAB11A, MYO5B and RAB11FIP2 is required for proper transport
CC       to the plasma membrane upon cholesterol depletion. Interacts with
CC       NPC2. {ECO:0000269|PubMed:19542231, ECO:0000269|PubMed:22095670}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:15671032}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15671032}. Cell membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:15671032}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15671032}. Note=Subfractionation of brush
CC       border membranes from proximal enterocytes suggests considerable
CC       association with the apical membrane fraction. Exists as a
CC       predominantly cell surface membrane expressed protein (By
CC       similarity). According to PubMed:15671032, localizes in a
CC       subcellular vesicular compartment rich in RAB5. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UHC9-1; Sequence=Displayed;
CC       Name=2; Synonyms=NPC1L1DELTAE15;
CC         IsoId=Q9UHC9-2; Sequence=VSP_015314;
CC       Name=3; Synonyms=NPCL1T;
CC         IsoId=Q9UHC9-3; Sequence=VSP_015312, VSP_015313;
CC       Name=4;
CC         IsoId=Q9UHC9-4; Sequence=VSP_054503, VSP_015314;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in liver. Also
CC       expressed in small intestine, pancreas, kidney, lung, pancreas,
CC       spleen, heart, gall bladder, brain, testis, stomach and muscle.
CC       {ECO:0000269|PubMed:10783261, ECO:0000269|PubMed:14976318,
CC       ECO:0000269|PubMed:15671032}.
CC   -!- INDUCTION: Expression is decreased in Caco-2 cells upon PPARD
CC       activation. {ECO:0000269|PubMed:15604518}.
CC   -!- PTM: Highly glycosylated. {ECO:0000250}.
CC   -!- POLYMORPHISM: Variations in NPC1L1 gene could be associated with
CC       non-response to ezetimibe treatment.
CC       {ECO:0000269|PubMed:15679830}.
CC   -!- MISCELLANEOUS: Target of cholesterol lowering drugs.
CC       {ECO:0000269|PubMed:21525977}.
CC   -!- SIMILARITY: Belongs to the patched family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF192522; AAF20396.1; -; mRNA.
DR   EMBL; AF192523; AAF20397.1; -; mRNA.
DR   EMBL; AY515256; AAS56939.1; -; mRNA.
DR   EMBL; AY437865; AAR97886.1; -; mRNA.
DR   EMBL; FJ481111; ACL18055.1; -; mRNA.
DR   EMBL; AC004938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236960; EAL23753.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61096.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61097.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61098.1; -; Genomic_DNA.
DR   EMBL; BC117178; AAI17179.1; -; mRNA.
DR   EMBL; BC143756; AAI43757.1; -; mRNA.
DR   CCDS; CCDS43575.1; -. [Q9UHC9-2]
DR   CCDS; CCDS5491.1; -. [Q9UHC9-1]
DR   CCDS; CCDS75587.1; -. [Q9UHC9-3]
DR   RefSeq; NP_001095118.1; NM_001101648.1.
DR   RefSeq; NP_001287896.1; NM_001300967.1. [Q9UHC9-3]
DR   RefSeq; NP_037521.2; NM_013389.2. [Q9UHC9-1]
DR   UniGene; Hs.567486; -.
DR   PDB; 3QNT; X-ray; 2.83 A; A=22-284.
DR   PDBsum; 3QNT; -.
DR   ProteinModelPortal; Q9UHC9; -.
DR   SMR; Q9UHC9; -.
DR   BioGrid; 118936; 1.
DR   IntAct; Q9UHC9; 1.
DR   STRING; 9606.ENSP00000289547; -.
DR   BindingDB; Q9UHC9; -.
DR   ChEMBL; CHEMBL2027; -.
DR   DrugBank; DB00973; Ezetimibe.
DR   GuidetoPHARMACOLOGY; 2629; -.
DR   SwissLipids; SLP:000001532; -.
DR   TCDB; 2.A.6.6.6; the resistance-nodulation-cell division (rnd) superfamily.
DR   iPTMnet; Q9UHC9; -.
DR   PhosphoSitePlus; Q9UHC9; -.
DR   BioMuta; NPC1L1; -.
DR   DMDM; 425906049; -.
DR   EPD; Q9UHC9; -.
DR   PaxDb; Q9UHC9; -.
DR   PeptideAtlas; Q9UHC9; -.
DR   PRIDE; Q9UHC9; -.
DR   Ensembl; ENST00000289547; ENSP00000289547; ENSG00000015520. [Q9UHC9-1]
DR   Ensembl; ENST00000423141; ENSP00000404670; ENSG00000015520. [Q9UHC9-3]
DR   GeneID; 29881; -.
DR   KEGG; hsa:29881; -.
DR   UCSC; uc003tlb.4; human. [Q9UHC9-1]
DR   CTD; 29881; -.
DR   DisGeNET; 29881; -.
DR   GeneCards; NPC1L1; -.
DR   H-InvDB; HIX0201184; -.
DR   HGNC; HGNC:7898; NPC1L1.
DR   HPA; CAB070127; -.
DR   HPA; CAB070128; -.
DR   MIM; 608010; gene+phenotype.
DR   neXtProt; NX_Q9UHC9; -.
DR   OpenTargets; ENSG00000015520; -.
DR   PharmGKB; PA31699; -.
DR   eggNOG; KOG1933; Eukaryota.
DR   eggNOG; ENOG410XR54; LUCA.
DR   GeneTree; ENSGT00800000124043; -.
DR   HOGENOM; HOG000036674; -.
DR   HOVERGEN; HBG003913; -.
DR   InParanoid; Q9UHC9; -.
DR   KO; K14461; -.
DR   OMA; LCLVPTF; -.
DR   OrthoDB; EOG091G00JD; -.
DR   PhylomeDB; Q9UHC9; -.
DR   TreeFam; TF300416; -.
DR   Reactome; R-HSA-265473; Trafficking of dietary sterols.
DR   GenomeRNAi; 29881; -.
DR   PRO; PR:Q9UHC9; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000015520; -.
DR   CleanEx; HS_NPC1L1; -.
DR   ExpressionAtlas; Q9UHC9; baseline and differential.
DR   Genevisible; Q9UHC9; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0031489; F:myosin V binding; IPI:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:HGNC.
DR   GO; GO:0030301; P:cholesterol transport; IMP:HGNC.
DR   GO; GO:0030299; P:intestinal cholesterol absorption; IMP:HGNC.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IMP:HGNC.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0015918; P:sterol transport; TAS:Reactome.
DR   InterPro; IPR032190; NPC1_N.
DR   InterPro; IPR003392; Ptc/Disp.
DR   InterPro; IPR000731; SSD.
DR   Pfam; PF16414; NPC1_N; 1.
DR   Pfam; PF02460; Patched; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Cholesterol metabolism; Complete proteome; Cytoplasmic vesicle;
KW   Disulfide bond; Glycoprotein; Lipid metabolism; Membrane;
KW   Polymorphism; Reference proteome; Signal; Steroid metabolism;
KW   Sterol metabolism; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22   1359       Niemann-Pick C1-like protein 1.
FT                                /FTId=PRO_0000023266.
FT   TOPO_DOM     22    284       Extracellular. {ECO:0000255}.
FT   TRANSMEM    285    305       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    306    351       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    373    632       Extracellular. {ECO:0000255}.
FT   TRANSMEM    633    653       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    654    666       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    667    687       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    688    696       Extracellular. {ECO:0000255}.
FT   TRANSMEM    697    717       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    718    742       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    743    763       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    764    776       Extracellular. {ECO:0000255}.
FT   TRANSMEM    777    797       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    798    846       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    847    867       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    868    882       Extracellular. {ECO:0000255}.
FT   TRANSMEM    883    903       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    904   1139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1140   1160       Helical; Name=10. {ECO:0000255}.
FT   TOPO_DOM   1161   1168       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1169   1189       Helical; Name=11. {ECO:0000255}.
FT   TOPO_DOM   1190   1191       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1192   1212       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM   1213   1236       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1237   1257       Helical; Name=13. {ECO:0000255}.
FT   TOPO_DOM   1258   1359       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      632    797       SSD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00199}.
FT   COMPBIAS    500    503       Poly-Leu.
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21525977}.
FT   CARBOHYD    132    132       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21525977}.
FT   CARBOHYD    244    244       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    416    416       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    431    431       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    464    464       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    479    479       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    497    497       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    506    506       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    626    626       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     33     90       {ECO:0000269|PubMed:21525977}.
FT   DISULFID     39     57       {ECO:0000269|PubMed:21525977}.
FT   DISULFID     78    125       {ECO:0000269|PubMed:21525977}.
FT   DISULFID     91    129       {ECO:0000269|PubMed:21525977}.
FT   DISULFID    113    254       {ECO:0000269|PubMed:21525977}.
FT   DISULFID    116    172       {ECO:0000269|PubMed:21525977}.
FT   DISULFID    189    197       {ECO:0000269|PubMed:21525977}.
FT   DISULFID    243    259       {ECO:0000269|PubMed:21525977}.
FT   DISULFID    256    263       {ECO:0000269|PubMed:21525977}.
FT   VAR_SEQ     723    724       RL -> GP (in isoform 3).
FT                                {ECO:0000303|PubMed:10783261}.
FT                                /FTId=VSP_015312.
FT   VAR_SEQ     725   1359       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10783261}.
FT                                /FTId=VSP_015313.
FT   VAR_SEQ     850    895       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054503.
FT   VAR_SEQ    1046   1072       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:10783261,
FT                                ECO:0000303|PubMed:14976318,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19325169}.
FT                                /FTId=VSP_015314.
FT   VARIANT      55     55       V -> L (non-response to ezetimibe
FT                                treatment; dbSNP:rs119457968).
FT                                {ECO:0000269|PubMed:15679830}.
FT                                /FTId=VAR_023369.
FT   VARIANT     510    510       M -> I (in dbSNP:rs1468384).
FT                                /FTId=VAR_056659.
FT   VARIANT    1233   1233       I -> N (in dbSNP:rs52815063).
FT                                {ECO:0000269|PubMed:15679830}.
FT                                /FTId=VAR_023370.
FT   VARIANT    1308   1308       E -> K (in dbSNP:rs217435).
FT                                /FTId=VAR_056660.
FT   CONFLICT   1073   1073       T -> A (in Ref. 1; AAF20396 and 7;
FT                                AAI43757). {ECO:0000305}.
FT   STRAND       34     40       {ECO:0000244|PDB:3QNT}.
FT   STRAND       47     49       {ECO:0000244|PDB:3QNT}.
FT   STRAND       55     58       {ECO:0000244|PDB:3QNT}.
FT   HELIX        68     77       {ECO:0000244|PDB:3QNT}.
FT   HELIX        79     81       {ECO:0000244|PDB:3QNT}.
FT   STRAND       84     86       {ECO:0000244|PDB:3QNT}.
FT   STRAND       88     90       {ECO:0000244|PDB:3QNT}.
FT   HELIX        93    109       {ECO:0000244|PDB:3QNT}.
FT   TURN        110    112       {ECO:0000244|PDB:3QNT}.
FT   HELIX       114    129       {ECO:0000244|PDB:3QNT}.
FT   HELIX       133    135       {ECO:0000244|PDB:3QNT}.
FT   STRAND      137    143       {ECO:0000244|PDB:3QNT}.
FT   STRAND      146    149       {ECO:0000244|PDB:3QNT}.
FT   STRAND      152    161       {ECO:0000244|PDB:3QNT}.
FT   HELIX       162    172       {ECO:0000244|PDB:3QNT}.
FT   HELIX       186    188       {ECO:0000244|PDB:3QNT}.
FT   STRAND      194    196       {ECO:0000244|PDB:3QNT}.
FT   HELIX       199    206       {ECO:0000244|PDB:3QNT}.
FT   TURN        209    212       {ECO:0000244|PDB:3QNT}.
FT   STRAND      215    223       {ECO:0000244|PDB:3QNT}.
FT   HELIX       225    228       {ECO:0000244|PDB:3QNT}.
FT   TURN        248    250       {ECO:0000244|PDB:3QNT}.
FT   TURN        256    258       {ECO:0000244|PDB:3QNT}.
FT   HELIX       260    262       {ECO:0000244|PDB:3QNT}.
SQ   SEQUENCE   1359 AA;  148728 MW;  594F698B48D66DE7 CRC64;
     MAEAGLRGWL LWALLLRLAQ SEPYTTIHQP GYCAFYDECG KNPELSGSLM TLSNVSCLSN
     TPARKITGDH LILLQKICPR LYTGPNTQAC CSAKQLVSLE ASLSITKALL TRCPACSDNF
     VNLHCHNTCS PNQSLFINVT RVAQLGAGQL PAVVAYEAFY QHSFAEQSYD SCSRVRVPAA
     ATLAVGTMCG VYGSALCNAQ RWLNFQGDTG NGLAPLDITF HLLEPGQAVG SGIQPLNEGV
     ARCNESQGDD VATCSCQDCA ASCPAIARPQ ALDSTFYLGQ MPGSLVLIII LCSVFAVVTI
     LLVGFRVAPA RDKSKMVDPK KGTSLSDKLS FSTHTLLGQF FQGWGTWVAS WPLTILVLSV
     IPVVALAAGL VFTELTTDPV ELWSAPNSQA RSEKAFHDQH FGPFFRTNQV ILTAPNRSSY
     RYDSLLLGPK NFSGILDLDL LLELLELQER LRHLQVWSPE AQRNISLQDI CYAPLNPDNT
     SLYDCCINSL LQYFQNNRTL LLLTANQTLM GQTSQVDWKD HFLYCANAPL TFKDGTALAL
     SCMADYGAPV FPFLAIGGYK GKDYSEAEAL IMTFSLNNYP AGDPRLAQAK LWEEAFLEEM
     RAFQRRMAGM FQVTFMAERS LEDEINRTTA EDLPIFATSY IVIFLYISLA LGSYSSWSRV
     MVDSKATLGL GGVAVVLGAV MAAMGFFSYL GIRSSLVILQ VVPFLVLSVG ADNIFIFVLE
     YQRLPRRPGE PREVHIGRAL GRVAPSMLLC SLSEAICFFL GALTPMPAVR TFALTSGLAV
     ILDFLLQMSA FVALLSLDSK RQEASRLDVC CCVKPQELPP PGQGEGLLLG FFQKAYAPFL
     LHWITRGVVL LLFLALFGVS LYSMCHISVG LDQELALPKD SYLLDYFLFL NRYFEVGAPV
     YFVTTLGYNF SSEAGMNAIC SSAGCNNFSF TQKIQYATEF PEQSYLAIPA SSWVDDFIDW
     LTPSSCCRLY ISGPNKDKFC PSTVNSLNCL KNCMSITMGS VRPSVEQFHK YLPWFLNDRP
     NIKCPKGGLA AYSTSVNLTS DGQVLDTVAI LSPRLEYSGT ISAHCNLYLL DSTSRFMAYH
     KPLKNSQDYT EALRAARELA ANITADLRKV PGTDPAFEVF PYTITNVFYE QYLTILPEGL
     FMLSLCLVPT FAVSCLLLGL DLRSGLLNLL SIVMILVDTV GFMALWGISY NAVSLINLVS
     AVGMSVEFVS HITRSFAIST KPTWLERAKE ATISMGSAVF AGVAMTNLPG ILVLGLAKAQ
     LIQIFFFRLN LLITLLGLLH GLVFLPVILS YVGPDVNPAL ALEQKRAEEA VAAVMVASCP
     NHPSRVSTAD NIYVNHSFEG SIKGAGAISN FLPNNGRQF
//
